Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

PHASE2CompletedINTERVENTIONAL

Enrollment

211

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

April 18, 2018

Study Completion Date

April 18, 2018

Conditions

Erosive Gastroesophageal Reflux Disease

Interventions

DRUG

DWP14012

tablet

DRUG

Esomeprazole

tablet

DRUG

DWP14012 placebo

tablet

DRUG

Esomeprazole placebo

tablet

Trial Locations (1)

Hanyang University Medical Center, Sungdong-gu